Financials • Investment Managers
$58.01 ▲ +1.23
(+2.17%)
MKT CAP: $4.33B • VOL: 1.01M
52W L $47 52W H $67
FHI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.80B | $1.63B | $1.61B |
| YoY Revenue Growth % | +10.3% | +1.4% | — |
| Gross Profit | $792.3M | $718.1M | $708.2M |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $513.9M | $361.5M | $387.5M |
| Operating Margin % | 28.5% | 22.1% | 24.1% |
| Net Income (GAAP) | $403.3M | $268.3M | $299.0M |
| EBITDA (Normalized) | $516.1M | $364.7M | $445.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $297.3M | $346.6M | $311.8M |
| Capital Expenditures (CapEx) | $2.8M | $4.0M | $72.4M |
| Free Cash Flow (FCF) | $294.6M | $342.5M | $239.4M |
| FCF Margin % | 16.4% | 21.0% | 14.9% |
| Return on Invested Capital (ROIC %) | 38.7% | 28.2% | 21.3% |
| Cash & Short-Term Equivalents | $582.5M | $504.4M | $262.0M |
| Total Debt (Short + Long Term) | $434.6M | $420.3M | $557.4M |
| Total Stockholders' Equity | $1.20B | $1.10B | $1.14B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FHI.